Holmium Laser for Reversal of Cerebral Artery Vasospasm

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1 R43 HL54398-01,
Agency Tracking Number: 29540
Amount: $687,478.00
Phase: Phase II
Program: SBIR
Awards Year: 1997
Solicitation Year: N/A
Solicitation Topic Code: N/A
Solicitation Number: N/A
Small Business Information
3404 N Orange Blossom Trail, Orlando, FL, 32804
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Peter Moulton
 () -
Business Contact
Phone: () -
Research Institution
Cerebral artery vasospasm may occur in patients suffering from subarachnoid hemorrhage and can resuneurological damage. The number of patients suffering from cerebral vasospasm is in excess of 20,000often produces permanently crippling effects or death in the 30-40 year old age group that exhibitspresent, there is no FDA approved procedure that is capable of permanently dilating the cerebral artbased treatment developed at Massachusetts General Hospital has been shown to reverse cerebral artercanine model. The goal of this Phase I effort will be to measure vasodilation as a function of laserex-vivo, living dog cerebral arteries in spasm. In Phase II, clinical testing would be started in orfavorable results observed in the canine model apply to humans. The long-term goal of the project woFDA approved laser system with fiber-optic delivery that would prevent the crippling effects of this

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government